-
-
Featured Care Areas
Transplant
Cancer Care
Brain & Spine Care
Heart Health
Bone Health
Dr Loh Kai-Lyn
Ophthalmologist
Specialty
Ophthalmology
Languages
English, Hokkien, Mandarin
Gender
Female
Insurance Panel
Prudential^
Please check with your insurance provider for more information, and for their most up-to-date list of panel doctors.
^Specialists may qualify to be on the Extended Panel (EP). You may enjoy selected panel benefits depending on your policy and riders.
Make an appointment
Experience
Dr Loh Kai-Lyn is an ophthalmologist at Parkway East Hospital, Singapore.
She treats general paediatric and adult eye conditions such as eye allergies, poor visual development, cataracts, glaucoma and diabetic retinopathy. Her specialty is in myopia management in both children and adults.
She was previously a consultant ophthalmologist at the Singapore National Eye Centre (SNEC). She is currently a visiting consultant at the Myopia Centre there.
Dr Loh graduated from the National University of Singapore (NUS). She went on to complete the “Leading Innovations in Healthcare and Education” course at the Harvard Macy Institute, USA.
At SNEC, she was a part of several ophthalmologists who established the Myopia Centre. She gained deep experience treating children with atropine eye drops, myopia control glasses and myopia control contact lenses. She also co-created the SNEC myopia course that received positive feedback from learners and won multiple awards both locally and internationally.
Besides her clinical work, she was a clinical faculty at NUS and Duke-NUS Medical School.
Dr Loh has published several peer-reviewed papers on clinical myopia control and has been invited to speak at international and local scientific conferences.
Associated treatments
- Diagnosis of eye disorders
- Use of laser equipment
- Treatment of eye disorders
Research & publications
Sim, B. X., Loh, K. L., Htoon, H. M., Sri, Y., Balakrishnan, M., Lin, P. C. P., Sim, R. Z. H., Lam, C. S. W., & Chia, A. W. L. (2025). Additive effect of Highly Aspherical Lenslet Target (HALT) spectacles to children inadequately controlled by Atropine monotherapy.
Donald Tan, Su Ann Tay, Kai-Lyn Loh, Audrey Chia (2016). Topical atropine in the control of myopia. PubMed, 5(6), 424-428.
Loh, K., Lu, Q., Tan, D., & Chia, A. (2015). Risk factors for Progressive myopia in the Atropine Therapy for Myopia Study. American Journal of Ophthalmology, 159(5), 945–949.
